---
title: "The building materials sector surged rapidly during trading, with NXBM and others hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232007576.md"
description: "The building materials sector quickly rose during the trading session, with EVERJOY HEALTH and NXBM hitting the daily limit, while Hainan Ruize and Puxin Co., Ltd. also saw gains"
datetime: "2025-03-17T01:44:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232007576.md)
  - [en](https://longbridge.com/en/news/232007576.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232007576.md)
generator: "portal-rs"
---

# The building materials sector surged rapidly during trading, with NXBM and others hitting the daily limit

The building materials sector quickly rose during the trading session, with EVERJOY HEALTH and NXBM hitting the daily limit, while Hainan RuiZe and Puxin Co., Ltd. also saw gains

### Related Stocks

- [002162.CN](https://longbridge.com/en/quote/002162.CN.md)
- [600449.CN](https://longbridge.com/en/quote/600449.CN.md)
- [002596.CN](https://longbridge.com/en/quote/002596.CN.md)
- [002225.CN](https://longbridge.com/en/quote/002225.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [China Jushi Co.: Net profit jumped 73.87% YoY on strong sales, margin gains, and robust cash flow](https://longbridge.com/en/news/296455427.md)
- [CMOC Group Declares Interim Dividend and Details Tax Arrangements for H Shareholders](https://longbridge.com/en/news/296383667.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**